Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05543785

Ketorolac Intravenous Regional Analgesia in Lower Limb Surgeries

Ketorolac for Intravenous Regional Analgesia in Lower Limb Orthopedic Surgeries Under Spinal Anesthesia: A Randomized Control Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
76 (estimated)
Sponsor
Mansoura University · Academic / Other
Sex
All
Age
19 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Tourniquet, a compressing device, otherwise its use in intravenous regional anesthesia, is commonly used in particular orthopedic surgeries. From the previous documented effectiveness and safety of intravenous (IV) administration of ketorolac in the circulatory-isolated limb as a part of intravenous regional anesthesia; we hypothesized that in orthopedic surgeries done with tourniquet, intravenous (IV) administration of ketorolac after tourniquet inflation, will act as intravenous regional analgesia. So, it will prolong the postoperative analgesic duration as a primary outcome.

Detailed description

This is a randomized controlled trial that tests the effecacy of the intravenous regional ketorolac in lower limb orthopedic surgeries with spinal anesthesia. The investigators will compare the effect of 30 mg ketorolac without local anesthetic in the injected intravenously in an isolated lower limb (with torniquet) versus intravenous 30 mg ketorolac administered 10 minutes before toniquet pressuerization on the postoperative analgesia. All patients will receive spinal anesthesia aiming for at least T12-L1 level. Postoperative standard analgesia will be paracetamol and diclofenac, given for both groups.

Conditions

Interventions

TypeNameDescription
DRUGKetorolacAfter confirmation of circulatory isolation of the operated limb by the inflated tourniquet, 30 mg ketorolac tromethamine diluted in normal saline in a total volume of 50 ml will be injected
OTHERControlAfter confirmation of circulatory isolation of the operated limb by the inflated tourniquet, 50 ml normal saline without drugs will be injected

Timeline

Start date
2022-11-01
Primary completion
2027-05-30
Completion
2027-12-30
First posted
2022-09-16
Last updated
2026-02-17

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05543785. Inclusion in this directory is not an endorsement.